DISEASE INDICATIONS: HIV/AIDS
MANUFACTURER: Merck
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Therapeutic Goods Administration (TGA)
Pifeltro, known by its generic name Doravirine, is a prescription medication used in the treatment of human immunodeficiency virus type 1 (HIV-1) infection. It belongs to the class of drugs known as non-nucleoside reverse transcriptase inhibitors (NNRTIs).
DISEASE INDICATIONS: Lung Cancer
MANUFACTURER: Eli Lilly Nederland B.V.
USAGE: Intravenous
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Portrazza, with its generic name Necitumumab, is a monoclonal antibody developed by Eli Lilly and Company. It received approval from the United States Food and Drug Administration (FDA) in late 2015, marking a significant advancement in the treatment of advanced squamous NSCLC.
CHARACTERISTICS
ACTIVE HALF-LIFE 15-18 HOURS
CLASSIFICATION SSRI INHIBITOR
DOSAGE MEN 30-90 MG/DAY
ACNE NO
WATER RETENTION NO
HBR POSSIBLE
HEPATOTOXICITY NO
AROMATIZATION NO
ACTIVE SUBSTANCE DAPOXETINE
FORM 10 PILLS X 30 MG
MANUFACTURER SUNRISE REMEDIES
CHARACTERISTICS
ACTIVE HALF-LIFE 15-18 HOURS
CLASSIFICATION SSRI INHIBITOR
DOSAGE MEN 30-90 MG/DAY
ACNE NO
WATER RETENTION NO
HBR POSSIBLE
HEPATOTOXICITY NO
AROMATIZATION NO
ACTIVE SUBSTANCE DAPOXETINE
FORM 10 PILLS X 60 MG
MANUFACTURER SUNRISE REMEDIES
CHARACTERISTICS
ACTIVE HALF-LIFE 15-18 HOURS
CLASSIFICATION SSRI INHIBITOR
DOSAGE MEN 30-90 MG/DAY
ACNE NO
WATER RETENTION NO
HBR POSSIBLE
HEPATOTOXICITY NO
AROMATIZATION NO
ACTIVE SUBSTANCE DAPOXETINE
FORM 10 PILLS X 90 MG
MANUFACTURER SUNRISE REMEDIES
